[1] |
ALDOKHAYEL S, NOUF A, KHALID A, et al. A novel mutation in ABCB6 associated with dyschromatosis universalis hereditaria in a Saudi family[J]. JAAD Case Rep, 2021, 19:97-99. doi:10.1016/j.jdcr.2021.11.017.
|
[2] |
ZELLER C, HINZMANN B, SEITZ S, et al. SASH1:a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer[J]. Oncogene, 2003, 22(19):2972-2983. doi:10.1038/sj.onc.1206474.
|
[3] |
XING Q H, WANG M T, CHEN X D, et al. A gene locus responsible for dyschromatosis symmetrica hereditaria (DSH) maps to chromosome 6q24.2-q25.2[J]. Am J Hum Genet, 2003, 73(2):377-382. doi:10.1086/377007.
|
[4] |
ZHOU D, WEI Z, DENG S, et al. SASH1 regulates melanocyte transepithelial migration through a novel Gαs-SASH1-IQGAP1-E-Cadherin dependent pathway[J]. Cell Signal, 2013, 25(6):1526-1538. doi:10.1016/j.cellsig.2012.12.025.
|
[5] |
ZHOU D, WEI Z, KUANG Z, et al. A novel P53/POMC/Gαs/SASH1 autoregulatory feedback loop activates mutated SASH1 to cause pathologic hyperpigmentation[J]. J Cell Mol Med, 2017, 21(4):802-815. doi:10.1111/jcmm.13022.
|
[6] |
ZHOU D, KUANG Z, ZENG X, et al. p53 regulates ERK1/2/CREB cascade via a novel SASH1/MAP2K2 crosstalk to induce hyperpigmentation[J]. J Cell Mol Med, 2017, 21(10):2465-2480. doi:10.1111/jcmm.13168.
|
[7] |
WU N, TANG L, LI X, et al. Identification of a novel mutation in SASH1 gene in a Chinese family with dyschromatosis universalis hereditaria and genotype-phenotype correlation analysis[J]. Front Genet, 2020, 11:841. doi:10.3389/fgene.2020.00841.
|
[8] |
ZHONG W L, WANG H J, LIN Z M, et al. Novel mutations in SASH1 associated with dyschromatosis universalis hereditaria[J]. Indian J Dermatol Venereol Leprol, 2019, 85(4):440. doi:10.4103/ijdvl.IJDVL_360_17.
|
[9] |
CAO L, ZHANG R, YONG L, et al. Novel missense mutation of SASH1 in a Chinese family with dyschromatosis universalis hereditaria[J]. BMC Med Genomics, 2021, 14(1):168. doi:10.1186/s12920-021-01014-w.
|
[10] |
CUI H, GUO S, HE H, et al. SASH1 promotes melanin synthesis and migration via suppression of TGF-β1 secretion in melanocytes resulting in pathologic hyperpigmentation[J]. Int J Biol Sci, 2020, 16(7):1264-1273. doi:10.7150/ijbs.38415.
|
[11] |
LIU J W, HABULIETI X, WANG R R, et al. Two novel SASH1 mutations in Chinese families with dyschromatosis universalis hereditaria[J]. J Clin Lab Anal, 2021, 35(6):e23803. doi:10.1002/jcla.23803.
|
[12] |
ARAKI Y, OKAMURA K, SAITO T, et al. Five novel mutations in SASH1 contribute to lentiginous phenotypes in Japanese families[J]. Pigment Cell Melanoma Res, 2021, 34(2):174-178. doi:10.1111/pcmr.12930.
|
[13] |
HWANG Y S, KIM Y J, KIM M O, et al. Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK[J]. Chem Biol Interact, 2017, 273:107-114. doi:10.1016/j.cbi.2017.06.005.
|
[14] |
LIM J W, HA J H, JEONG Y J, et al. Anti-melanogenesis effect of dehydroglyasperin C through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16F1 melanoma cells[J]. Pharmacol Rep, 2018, 70(5):930-935. doi:10.1016/j.pharep.2018.02.024.
|
[15] |
RACHMIN I, OSTROWSKI S M, WENG Q Y, et al. Topical treatment strategies to manipulate human skin pigmentation[J]. Adv Drug Deliv Rev, 2020, 153:65-71. doi:10.1016/j.addr.2020.02.002.
|